|
PK-RNN-V E A deep learning model approach to vancomycin therapeutic drug monitoring using electronic health record data
|
|
2025년 12월 11일 발표 참고문헌
|
|
Population pharmacokinetics of efpeglenatide in individuals with obesity and with type 2 diabetes
|
|
Artificial intelligence in drug development.
|
|
Population pharmacokinetics and pharmacodynamics of cefazolin using total and unbound serum concentrations in patients with high body weight
|
|
Population pharmacokinetics/pharmacodynamics analysis confirming biosimilarity of SB16 to reference denosumab
|
|
Response surface model for anesthetic drug interactions
|
|
The operational multiple dosing half-life a key to defining drug accumulation in patients and to designing extended release dosage forms
|
|
A Mechanism-Based Population Pharmacokinetics Model of Erythropoietin in Premature Infants and Healthy Adults Following Multiple Intravenous Doses.
|
|
What Does It Take to Transform Real-World Data Into Real-World Evidence?
|